Bajaj Healthcare Limited — Others, 11-02-2025: Statement of deviation(s) or variation(s) under Reg. 32

Bajaj Healthcare Limited has provided a statement confirming no deviation in the utilization of proceeds from its recent preferential issue of equity shares and convertible warrants, which raised ₹204.97 crore. The audit committee reviewed the usage for the quarter ending December 2024, affirming that funds have been allocated as originally intended, primarily for debt repayment and capital expenditure. A minor adjustment of ₹2.25 crore was shifted to cover an unsecured loan from the promoter, which was approved through an updated definition of general corporate purpose. This clarity reinforces investor confidence, indicating prudent financial management.